價格 | ¥1060 |
包裝 | 2mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:化合物 BB-Cl-Amidine hydrochloride | 英文名稱:BB-Cl-Amidine hydrochloride |
CAS:2436747-41-8 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T10482L |
名稱 | BB-Cl-Amidine hydrochloride |
描述 | BB-Cl-Amidine hydrochloride is an inhibitor of peptidylarginine deminase (PAD) [1]. |
體內(nèi)活性 | Treatment with BB-Cl-amidine subtly reduces splenomegaly in MRL/lpr mice, while there is a trend towards increased circulating levels of anti-NET antibodies with PAD inhibitor treatment. However, neither PAD inhibitor affected body weight or total IgG levels. In fact, treatment with both Cl-amidine and BB-Cl-amidine significantly improves endothelium-dependent vasorelaxation. The BB-Cl-amidine group also shows a strong trend towards downregulation of IRGs. Treatment with either Cl-amidine or BB-Cl-amidine significantly improves muzzle alopecia, in many cases preventing it entirely [1]. Animal Model: MRL/lpr mice [1]. Dosage: 1 mg/kg. Administration: Subcutaneous injection daily from 8 to 14 weeks of age. Result: Significantly improved endothelium-dependent vasorelaxation and showed a strong trend towards downregulation of IRGs. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 100 mg/mL (201.44 mM) |
關鍵字 | 1802637-39-3 free base | BB Cl Amidine hydrochloride | BBClAmidine hydrochloride | BB-Cl-Amidine Hydrochloride | 1802637-39-3 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學試劑,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
上海研紛生化科技有限公司
|
2025-01-02 | |
詢價 |
VIP5年
|
濟南銘嘉醫(yī)藥技術有限公司
|
2024-12-25 | |
詢價 |
VIP5年
|
湖北惠擇普醫(yī)藥科技有限公司
|
2024-12-12 |